Elevance Health stock rises 3.83% and outperforms market during rough session
Updated
Updated · MarketWatch · Apr 29
Elevance Health stock rises 3.83% and outperforms market during rough session
6 articles · Updated · MarketWatch · Apr 29
Shares closed at $376.63 on Wednesday, marking a third consecutive day of gains and surpassing its 50-day average trading volume with 2.5 million shares traded.
Elevance Health outperformed major competitors, with UnitedHealth up 1.08%, Cigna up 2.60%, and Humana up 5.83%, despite the S&P 500 and Dow Jones both declining.
The stock remains 11.22% below its 52-week high of $424.24 reached on May 12, reflecting ongoing volatility in the broader market.
What risks does the new law firm investigation pose to Elevance Health's stock rally?
How will Elevance's AI strategy combat rising medical costs and regulatory hurdles?
Will new CMS transparency rules finally curb the power of giant health insurers?
Can the Medicare rate hike offset the massive drop in Medicaid enrollment for insurers?
As insurers use AI for approvals, what protects patients from wrongful care denials?